Comparing the Garmin Venu 3 / Garmin Venu 4 for Non-Invasive Vital Sign Monitoring to a Hospital-Grade Monitor
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorZiekenhuis Oost-Limburg
About this trial
This clinical trial evaluates the accuracy of the Garmin Venu 3 / Garmin Venu 4 smartwatch in measuring vital signs (heart rate, respiratory rate, SpO₂) compared to the clinically validated Philips IntelliVue X2. The study aims to determine whether the consumer-grade smartwatch can provide reliable data for remote patient monitoring, early hospital discharge, and chronic disease management, offering a more accessible and affordable alternative to MDR-certified devices.
Eligibility criteria
Qualifiers
Provide signed and dated informed consent
Adults older than 18 years of age
Speak and understand the Dutch language
Hospitalized for at least another 24 hours
Disqualifiers
Life expectancy is less than 30 days
Patient is isolated due to infection control
Trial design
Treatments tested in this trial
- Garmin Venu 3 or Garmin Venu 4 + Philips Intellivue X2
- Smartwatch rating scale questionnaire
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov